Contaminant in Supply Found to Cause Heparin Allergic Reactions
Those harmed by Heparin my complete the form below for a complimentary lawsuit review.
On March 5, 2008, The U.S. Food and Drug Administration (FDA), which has been investigating the cause of allergic reactions in Baxter International Inc.'s blood thinner Heparin, said it has found a contaminant in the supply chain. The inquiry had been sparked by an onslaught of allergic reactions from the popular blood-thinner.
An agency spokesperson told the Chicago Tribune newspaper that it had found a heparin-like compound that is not heparin in the drug's supply chain. The contaminant was found in "5 to 20" percent of the Heparin tested, however, the FDA said that it still has not found the root cause of the problem.
In a conference call with reporters, the spokesperson said the agency was investigating "whether the introduction was accidental or it was deliberate."
If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.
see also:
Heparin & Allergic Reactions
Contaminant in Supply Found to Cause Heparin Allergic ReactionsAllergic Reactions Due to Contaminant In Heparin Supply--Lawsuit info
Heparin Laboratories
Scientific Protein Laboratories Responds to Alarm Over Tainted HeparinThe response of Scientific Protein Laboratories regarding Heparin
Heparin Recall Sparks Inquiry
Congressmen: How did it happen? Probe into Heparin Recall GrowsFind out how the Heparin recall sparks congressional inquiry
